Entheon Biomedical Corp. (CSE:ENBI)

Canada flag Canada · Delayed Price · Currency is CAD
0.100
0.00 (0.00%)
Dec 18, 2025, 3:06 PM EST
-41.18%
Market Cap 1.39M
Revenue (ttm) n/a
Net Income (ttm) -342.81K
Shares Out 13.86M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,000
Average Volume 17,716
Open 0.095
Previous Close 0.100
Day's Range 0.095 - 0.100
52-Week Range 0.070 - 0.450
Beta 1.47
RSI 53.30
Earnings Date Mar 5, 2026

About Entheon Biomedical

Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Timothy Ko
Employees 1
Stock Exchange Canadian Securities Exchange
Ticker Symbol ENBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.